Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Healthcare Shares
Buy Pro Medicus and these ASX healthcare stocks now
Share Gainers
These 4 small ASX shares are already up more than 19% in 2024!
Small Cap Shares
Buy these small cap ASX shares in September: Bell Potter
Earnings Results
Medical Developments share price leaps 5% on FY22 revenue boost
Share Fallers
Why Alliance, Aurizon, MVP, and Suncorp shares are dropping today
Share Fallers
Here's why the Medical Developments share price is sinking 17% on Monday
Healthcare Shares
Medical Developments share price halted amid 'significant near-term opportunities'
Share Gainers
Why Core Lithium, MVP, Rio Tinto, and South32 shares are rising today
Healthcare Shares
Why the Medical Developments International (ASX:MVP) share price is rocketing 32% higher
Earnings Results
Medical Developments International (ASX:MVP) share price on watch as losses widen
Healthcare Shares
Medical Developments (ASX:MVP) share price hits new 52 week low
Share Fallers
Medical Developments (ASX:MVP) share price falls on $13 million loss
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
